Genisphere and Sidney Kimmel Cancer Center at Jefferson Health Collaborate on the Treatment of Pancreatic Cancer
Retrieved on:
Wednesday, May 30, 2018
HATFIELD, Pa. and PHILADELPHIA, May 30, 2018 /PRNewswire/ -- Genisphere LLC and the Sidney Kimmel Cancer Center at Jefferson Health announced a research collaboration to develop novel approaches to treat pancreatic cancer.
Key Points:
- HATFIELD, Pa. and PHILADELPHIA, May 30, 2018 /PRNewswire/ -- Genisphere LLC and the Sidney Kimmel Cancer Center at Jefferson Health announced a research collaboration to develop novel approaches to treat pancreatic cancer.
- According to their Sponsored Research Agreement, investigators at the Sidney Kimmel Cancer Center and Genisphere will combine expertise to optimize 3DNA-based therapeutics designed to target and kill pancreatic tumors.
- Projects will include delivering small molecule therapeutics as well as siRNA formulated with pancreatic tumor-targeting molecules on Genisphere's 3DNA nanocarrier.
- The Principal Investigator on the project is Jonathan Brody, Ph.D., Co-director of the Jefferson Pancreatic, Biliary and Related Cancer Center and Director of Surgical Research.